Related references
Note: Only part of the references are listed.Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer
Steven H. Lin et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Trastuzumab with trimodality treatment for esophageal adenocarcinoma with HER2 overexpression: NRG Oncology/RTOG 1010.
Howard Safran et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiation therapy (CRT): First results of the CheckMate 577 study
R. J. Kelly et al.
ANNALS OF ONCOLOGY (2020)
Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial
G. A. von Dobeln et al.
DISEASES OF THE ESOPHAGUS (2019)
Effects of neoadjuvant chemoradiotherapy vs chemotherapy alone on the relief of dysphagia in esophageal cancer patients: secondary endpoint analysis in a randomized trial
B. Sunde et al.
DISEASES OF THE ESOPHAGUS (2019)
Combined Modality Therapy for Management of Esophageal Cancer: Current Approach Based on Experiences from East and West
Omeed Moaven et al.
SURGICAL CLINICS OF NORTH AMERICA (2019)
The benefit of taxane-based therapies over fluoropyrimidine plus platinum (FP) in the treatment of esophageal cancer: a meta-analysis of clinical studies
Tao Wang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Neoadjuvant Therapy Vs Upfront Surgery for Clinical T2N0 Esophageal Cancer: A Systematic Review
Biniam Kidane et al.
ANNALS OF THORACIC SURGERY (2019)
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Salah-Eddin Al-Batran et al.
LANCET (2019)
Esophageal and Esophagogastric Junction Cancers, Version 2.2019
Jaffer A. Ajani et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Neoadjuvant chemoradiotherapy or chemotherapy for gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis
Fausto Petrelli et al.
GASTRIC CANCER (2019)
Definitive Chemoradiotherapy Versus Trimodality Therapy for Resectable Oesophageal Carcinoma: Meta-analyses and Systematic Review of Literature
Daan M. Voeten et al.
WORLD JOURNAL OF SURGERY (2019)
Chinese guidelines for diagnosis and treatment of esophageal carcinoma 2018
[Anonymous]
CHINESE JOURNAL OF CANCER RESEARCH (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Perioperative chemotherapy with or without epidermal growth factor receptor blockade in unselected patients with locally advanced oesophagogastric adenocarcinoma: Randomized phase II study with advanced biomarker program of the German Cancer Society (AIO/CAO STO-0801)
Michael Stahl et al.
EUROPEAN JOURNAL OF CANCER (2018)
Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta-analysis
Kelvin K. W. Chan et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial
Bo Jan Noordman et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
Annemieke Cats et al.
LANCET ONCOLOGY (2018)
Neoadjuvant chemotherapy in advanced gastric and esophago-gastric cancer. Meta-analysis of randomized trials
Federico Coccolini et al.
INTERNATIONAL JOURNAL OF SURGERY (2018)
Neoadjuvant therapy or upfront surgery? A systematic review and meta-analysis of T2N0 esophageal cancer treatment options
F. C. Mota et al.
INTERNATIONAL JOURNAL OF SURGERY (2018)
Role of Postoperative Concurrent Chemoradiotherapy for Esophageal Carcinoma: A meta-analysis of 2165 Patients
Jingjing Kang et al.
JOURNAL OF CANCER (2018)
The role of definitive chemoradiotherapy versus surgery as initial treatments for potentially resectable esophageal carcinoma
Ming-Wei Ma et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2018)
Comparative Effectiveness of Neoadjuvant Treatments for Resectable Gastroesophageal Cancer: A Network Meta-Analysis
Zhaolun Cai et al.
FRONTIERS IN PHARMACOLOGY (2018)
Induction therapy for clinical stage T2N0M0 esophageal cancer A systematic review and meta-analysis
Hong-Wei Lv et al.
MEDICINE (2018)
Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial
Yusuke Shimodaira et al.
BRITISH JOURNAL OF CANCER (2018)
Meta-analysis of survival benefit with postoperative chemoradiotherapy in patients of lymph node positive esophageal carcinoma
H. Luo et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
Surrogate end-points for overall survival in 22 neoadjuvant trials of gastro-oesophageal cancers
Fausto Petrelli et al.
EUROPEAN JOURNAL OF CANCER (2017)
NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
Somnath Mukherjee et al.
EUROPEAN JOURNAL OF CANCER (2017)
Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): Long-term results of a controlled randomised trial
Michael Stahl et al.
EUROPEAN JOURNAL OF CANCER (2017)
Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance)
Charles S. Fuchs et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial
David Cunningham et al.
LANCET ONCOLOGY (2017)
Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial
Derek Alderson et al.
LANCET ONCOLOGY (2017)
Concurrent neoadjuvant chemoradiotherapy could improve survival outcomes for patients with esophageal cancer: a meta-analysis based on random clinical trials
Baoxing Liu et al.
ONCOTARGET (2017)
Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial
Mohan Suntharalingam et al.
JAMA ONCOLOGY (2017)
Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma A Network Meta-analysis
Sandro Pasquali et al.
ANNALS OF SURGERY (2017)
Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy plus /- cetuximab in oesophageal cancer
T. Crosby et al.
BRITISH JOURNAL OF CANCER (2017)
Utility of dysphagia grade in predicting endoscopic ultrasound T-stage of non-metastatic esophageal cancer
T. C. Fang et al.
DISEASES OF THE ESOPHAGUS (2016)
Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction
Jun Wang et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2015)
Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation
F. Klevebro et al.
EJSO (2015)
Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer
Abraham J. Wu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Systematic review and network meta-analysis: neoadjuvant chemoradiotherapy for locoregional esophageal cancer
Ta-Chen Huang et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2015)
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Joel Shapiro et al.
LANCET ONCOLOGY (2015)
Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials
Vera Oppedijk et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901
Christophe Mariette et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer
J. A. Ajani et al.
ANNALS OF ONCOLOGY (2013)
Therapy for Locally Advanced Adenocarcinoma of the Gastroesophageal Junction: Optimizing Outcome
Lawrence Kleinberg
SEMINARS IN RADIATION ONCOLOGY (2013)
PG 9.04 Oesophagogastric cancer: A case for perioperative chemotherapy
M. Ychou
EUROPEAN JOURNAL OF CANCER (2012)
Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection
Stephen R. Smalley et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial
Bryan H. Burmeister et al.
EUROPEAN JOURNAL OF CANCER (2011)
Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954
Christoph Schuhmacher et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer
William H. Allum et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Share Paper
